Sentinel lymph node detection in gastric cancer using a dual tracer (Superparamagnetic iron oxide and methylene blue): a prospective study with histological and OSNA validation. (2026)

Peer-Reviewed Study · Escalera-Pérez R, Medina-Achirica C, García-Molina FJ, Del Rio-Ignacio JJ, Lagares-Franco C, Estella A, Mateo-Vallejo FA · March 19, 2026

Escalera-Pérez R et al., 2026-03-19: Spanish ex vivo study of dual-tracer sentinel node detection in gastric cancer using superparamagnetic iron oxide plus methylene blue, with OSNA and histology.

Dual-tracer sentinel node mapping in gastric cancer proved feasible and accurate.

Escalera-Pérez R et al., 2026-03-19: Spanish ex vivo study of dual-tracer sentinel node detection in gastric cancer using superparamagnetic iron oxide plus methylene blue, with OSNA and histology. C7 (non-breast cancer). Study type: ex vivo diagnostic study (Sci Rep 2026;16); University Hospital of Jerez de la Frontera, Spain. N not stated in the abstract. Methylene blue concentration/dose not stated. Funder/conflicts not stated in the abstract. Shows methylene blue remains in use as the visible-dye component of dual-tracer mapping outside breast surgery. Study type: uncontrolled series.